Bradley J A, Ledingham I M, Hamilton D N
Intensive Care Med. 1981 Apr;7(3):105-8. doi: 10.1007/BF01738611.
The cell-mediated immunity (CMI) of 47 critically ill surgical patients admitted to an Intensive Therapy Unit was assessed by their response to recall skin antigens and found to be markedly reduced. Thirty-seven patients showed no reaction to initial skin testing (NR), and there were 21 deaths in this group. Ten patients reacted (R) to initial skin testing and only one of these patients died (p less than 0.025). Repeat skin testing was performed on 22 NR patients. Eight became R on repeat testing and there was one death in this group, whilst 14 remained NR and there were 11 deaths in this group (p less than 0.025). The major clinical difference between R and NR patients was a greater incidence of severe sepsis in the NR patients. These findings suggest that the use of recall skin antigens to assess CMI may be a valuable investigation in critically ill surgical patients and that initial and persisting failure to react to skin tests is associated with a poor outcome.
对收入重症监护病房的47例重症外科患者,通过他们对回忆性皮肤抗原的反应来评估其细胞介导免疫(CMI),结果发现其明显降低。37例患者对初始皮肤试验无反应(NR),该组中有21例死亡。10例患者对初始皮肤试验有反应(R),其中仅1例死亡(p<0.025)。对22例NR患者进行了重复皮肤试验。8例在重复试验时转为R,该组中有1例死亡,而14例仍为NR,该组中有11例死亡(p<0.025)。R与NR患者之间的主要临床差异在于NR患者中严重脓毒症的发生率更高。这些发现表明,使用回忆性皮肤抗原评估CMI可能是重症外科患者一项有价值的检查,并且初始及持续对皮肤试验无反应与不良预后相关。